Esketamine Programme

Disclaimer: The availability of esketamine treatment at UKAT is currently still being determined, as we prioritise adhering to government recommendations and ensuring the safety of our clients. We remain committed to offering effective addiction treatment alternatives and will keep you informed of any updates. Please contact our admissions team for the latest information.

Esketamine is a groundbreaking new drug that was approved by the Medical and Healthcare Products Regulatory Agency (MHRA) in 2020. Since then, it has been making waves in the mental health field with huge success particularly in treating major depressive disorder where other medications have failed.

UKAT London Clinic is proud to offer an exclusive esketamine treatment programme as part of our mission to help you reach mental and emotional wellness. Our team consists of top-tier therapists, doctors and psychiatrists, all with a wealth of experience in esketamine treatment. They will be on hand to guide you through this potentially life-changing programme in the comfort of our private facility.

Esketamine programme nasal spray

How does esketamine work?

Unlike other antidepressants that work by increasing neurotransmitters such as serotonin, dopamine and norepinephrine, esketamine stimulates glutamate – the most abundant excitatory messenger in the brain. As the levels of glutamate increase, communication between brain cells is invigorated and the prefrontal cortex becomes more active. These new connections in the brain work to reverse the damage caused by chronic stress and give you much needed relief from your depression.

The results of esketamine are almost instant, with our clients reporting a significant decrease in depressive symptoms within hours of taking it. This is a marked difference when compared with other antidepressants which often take several weeks for users to notice a difference.

Studies have even shown that individuals who suffered from suicidal ideations experienced a decline in these tendencies from 64% to 20% after only three months of esketamine treatment.

What can I expect from esketamine treatment?

Our facilities are the epitome of style and comfort, embodying warmth, relaxation and tranquillity. Esketamine is a self administered nasal spray device which you self administer under the care of a nurse in a relaxed environment. Throughout this time, our qualified nurse will closely monitor your heart rate and blood pressure to ensure you are comfortable throughout treatment.

It is possible that you will experience some minor side effects for about two hours after taking esketamine. Some people report:

  • Dizziness
  • Feeling drowsy
  • Feelings of happiness
  • Disassociation (feeling disconnected from your body)
  • Changes in perception of touch and taste
  • Nausea
  • Headaches

Esketamine programme woman with headache

While these are some of the most commonly reported side effects, you may only experience one or two, or nothing at all. Generally speaking, first-time esketamine users will likely have some side effects, but these tend to subside down the line as you continue on your esketamine course.

After being monitored for two hours at our clinic, you will be free to go about your usual business. We do, however, advise our clients not to drive or use heavy machinery until the day after treatment. After your esketamine session, you can expect to leave feeling fully revitalised and refreshed.

There is a positive mental health and wellbeing programme that runs alongside the treatment which we recommend doing as part of a package. Esketamine treatment alone will not confront any underlying causes of the depression; addressing the mind and body as a whole is the most effective way to support the treatment.

How often do I need esketamine?

The frequency and dose of the esketamine treatment will depend on your individual circumstances and will be determined by your consultant. This treatment is not suitable for everyone but begins with a twice weekly esketamine treatment. Then under the recommendation of the Consultant will gradually taper to maintenance doses once a week and then once every two weeks.

We will monitor your response to esketamine and work alongside your consultant to assess any changes in your symptoms. Depending on your results the esketamine treatment should be completed in six months or less.

Why choose us for esketamine treatment?

UKAT London Clinic is ideally located just off Harley Street in the centre of London. Once you walk through our doors, the hustle and bustle of the city is left behind. We provide our clients with a luxurious, high-end space where you can truly let go of any worries and sink into some precious you-time.

Esketamine programme illustration of esketamine

Our highly qualified team has one main goal, and that is to help you reach optimal wellness. Our primary focus is to provide you with everything you need to achieve a higher state of psychological health and emotional balance.

Esketamine is a safe and extremely effective treatment for treatment resistant depression, and with our assistance, you can begin to feel like a brand new version of yourself. Not only will our esketamine programme help you to feel more content and calm in your daily life, but you will also notice improvements in your sleep patterns, self-confidence and overall well-being.

What’s next?

Through clinical trials and a multitude of positive case studies, esketamine has shown great promise in the safe treatment of major depressive disorder and other mental health issues. Its rapid, robust results are revolutionising the way we help individuals suffering from debilitating symptoms. UKAT LOndon Clinic is excited to provide our clients with this pioneering treatment in conjunction with innovative therapies and well-being sessions that are completely tailored to meet your needs.

If you would like to take part in our exclusive esketamine programme, or if you have any questions about the treatment, please do not hesitate to contact us for an assessment with one of our consultant psychiatrists.